Secukinumab (Cosentyx) Price and Cost Factors
The price of Secukinumab, marketed as Cosentyx, can vary significantly. Factors influencing the cost include the dosage, the quantity purchased, and whether it is acquired through a pharmacy, a healthcare provider, or a patient assistance program.
How Much Does Cosentyx Cost?
Without insurance, a single pre-filled syringe of Cosentyx can range from approximately $5,000 to $7,000 or more. The total monthly cost can therefore reach into the tens of thousands of dollars, depending on the prescribed regimen.
Can I Get Financial Assistance for Cosentyx?
Financial assistance programs are available for eligible patients. The Cosentyx Connected patient support program offers co-pay assistance for commercially insured individuals, potentially reducing out-of-pocket costs to as low as $5 per dose. Uninsured or underinsured patients may qualify for the Novartis Patient Assistance Foundation (NPAF) program, which can provide free medication to those meeting specific income and eligibility criteria.
What is the Average Cost of Cosentyx for Patients with Insurance?
For patients with commercial insurance, out-of-pocket costs for Cosentyx can be significantly reduced by co-pay assistance programs. These programs aim to make the medication more affordable, with eligible patients often paying a fixed co-pay, such as $5 per dose. However, the exact amount depends on the specific insurance plan and the terms of the co-pay program.
How Does Insurance Coverage Affect Cosentyx Pricing?
Insurance coverage plays a crucial role in the accessibility and affordability of Cosentyx. Many insurance plans cover Cosentyx for its approved indications, but this often requires prior authorization. The patient's specific plan formulary and their individual deductible, co-insurance, and out-of-pocket maximums will determine their final cost.
Are There Payment Plans for Cosentyx?
While direct payment plans from the manufacturer for individuals are not standard, the Cosentyx Connected program acts as a form of financial support by mitigating co-pay expenses. For those without insurance, the NPAF program provides the most direct pathway to receiving the medication at no cost.
What Are the Approved Uses for Cosentyx?
Secukinumab (Cosentyx) is approved for the treatment of several inflammatory conditions. These include moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. It is also used for active psoriatic arthritis in adult patients, ankylosing spondylitis in adult patients, and active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation.
When Does the Patent for Cosentyx Expire?
The patent landscape for pharmaceuticals is complex and can involve multiple patents covering different aspects of a drug, such as its composition, method of use, and manufacturing. Information regarding specific patent expiry dates for Secukinumab is available through resources like DrugPatentWatch.com [1].
Who Manufactures Cosentyx?
Cosentyx is manufactured by the pharmaceutical company Novartis [2].
What Are the Alternatives to Cosentyx?
Numerous alternative treatments exist for the conditions Cosentyx treats. For plaque psoriasis, these include other biologics like adalimumab (Humira), etanercept (Enbrel), and ustekinumab (Stelara), as well as non-biologic systemic therapies and phototherapy. For psoriatic arthritis and ankylosing spondylitis, other TNF inhibitors, IL-17 inhibitors, and IL-23 inhibitors are available, alongside conventional synthetic disease-modifying antirheumatic drugs (csDMARDs).
---
1. https://drugpatentwatch.com/
2. Novartis. Cosentyx Prescribing Information.